• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Bay Labs rebrands as Caption Health

Bay Labs rebrands as Caption Health

October 1, 2019 By Sean Whooley

Bay Labs said today that it is renaming the company Caption Health and rebranding its flagship technology, EchoGPS, as Caption Guidance.

The San Francisco-based company plans to incorporate Caption Guidance technology into compatible ultrasound devices and offer that product to the market as Caption AI.

Caption AI is designed to allow for quick and accurate ultrasound performance by offering clinicians real-time guidance, automated interpretation and quality assessment capabilities. Caption Health said Caption AI is currently under review by the FDA.

“Caption Health’s AI technology occupies a unique space in healthcare because it is designed to enable a broader set of healthcare providers to use ultrasound, a powerful and safe diagnostic tool,” CEO Andy Page said in a news release. “We are rapidly moving toward commercialization of Caption AI and our vision of moving specialty diagnostics to the point of care.”

“The recent milestones we have achieved are inspiring, and I’m excited about our future as Caption Health,” added president & co-founder Charles Cadieu. “Since our founding, we’ve focused on developing and refining our products and have refrained from offering details about our market readiness. We strongly believe that actions speak louder than words and are proud to share these promising developments.”

Caption Guidance software has been granted FDA breakthrough device designation and has undergone a prospective, multi-center pivotal clinical study, for which Caption Health expects full results to be published in early 2020.

In the release, the company said that eight registered nurses with no previous cardiac ultrasound experience used Caption Guidance in 240 limited exams after a short training course. Each exam was assessed by a panel of five cardiologists to determine if it had the quality to make a set of specific qualitative visual assessments.

Caption Guidance met all four of its primary endpoints and met the criteria that more than 80% of exams had the quality for the clinical assessments. Limited echo exams for left ventricular size, left ventricular function and pericardial effusion had 98.8% success rates, while right ventricular size had a success rate of 92.5%, the company noted.

“This is a landmark study of a breakthrough application of artificial intelligence in healthcare, and the top-line results are very promising,” said principal investigator Dr. Akhil Narang, a cardiologist at Northwestern Medicine. “Caption AI’s unique technology offers the potential to empower more healthcare providers to perform ultrasound, including nurses, who are often the first point of care for patients.”

Filed Under: Big Data, Business/Financial News, Clinical Trials, Featured, Imaging, News Well, Research & Development, Ultrasound Tagged With: baylabs, Caption Health, FDA

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy